中銀香港(02388.HK)指施政報告為港長遠發展創造更有利條件
中銀香港(02388.HK)歡迎行政長官任內第二份《施政報告》,中銀香港副董事長兼總裁孫煜認為,《施政報告》為本港長遠發展及繁榮安定創造更有利條件。
孫煜表示,《施政報告》提出發展「總部經濟」,鼓勵尤其以亞太區為業務核心的企業遷冊來港,讓外國在港公司人員可「一簽多行」到內地,以及重啟「資本投資者入境計劃」等舉措將有助吸引企業及人才到港,提升香港經濟發展可持續性。
孫煜認為,《施政報告》中提出支持金融和創新科技發展的各項措施,將有利香港特區政府推進「南金融、北創科」的重要發展佈局,透過加強金融和創科的有機結合達致產業結構更多元化,提升本港經濟韌力之餘,亦能增強香港在全球經濟中的競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.